BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28331021)

  • 21. Posaconazole for treatment of refractory invasive fungal disease.
    Notheis G; Tarani L; Costantino F; Jansson A; Rosenecker J; Friederici D; Belohradsky BH; Reinhardt D; Seger R; Schweinitz DV; Wintergerst U
    Mycoses; 2006; 49 Suppl 1():37-41. PubMed ID: 16961581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain Abscesses Due to Aspergillus nidulans Infection During Induction Chemotherapy for Acute Lymphoblastic Leukemia.
    Sadarangani M; Harvey M; McDonald A; Speert DP; Dix D
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):e384-6. PubMed ID: 25985238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for a eumycetoma infection caused by Aspergillus in an immunocompromised host: a case report.
    Hopps S; Roach A; Yuen C; Borders E
    Transpl Infect Dis; 2015 Feb; 17(1):94-7. PubMed ID: 25537527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation.
    Takeda K; Morioka D; Matsuo K; Endo I; Sekido H; Moroboshi T; Togo S; Shimada H
    Transplant Proc; 2007 Dec; 39(10):3505-8. PubMed ID: 18089422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
    Uçan ES; Avkan Oğuz V; Güngör O; Gülşen A; Uğural Sezak N; Tertemiz KC; Ceylan E; Kargi A; Balci P; Ada E; Sanli A
    Tuberk Toraks; 2006; 54(1):75-9. PubMed ID: 16615023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal myocardial aspergillosis in an immunosuppressed child.
    Ozsahin H; Wacker P; Brundler MA; Starobinski M; Helg C; Pastore Y; Miralbell R; Hanquinet S; Gervaix A; Chapuis B; Humbert J
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):456-9. PubMed ID: 11878582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
    Hashimoto M; Honda Y; Fujishima T
    Nihon Kokyuki Gakkai Zasshi; 2007 Dec; 45(12):957-61. PubMed ID: 18186242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral voriconazole for invasive fungal skull base infection.
    Parsonage MJ; Stafford ND; Lillie P; Moss PJ; Barlow G; Thaker H
    J Laryngol Otol; 2010 Sep; 124(9):1010-3. PubMed ID: 20028605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posaconazole responsive cerebral aspergillosis in an immunocompetent adult.
    Ellenbogen JR; Waqar M; Denning DW; Cooke RP; Skinner DW; Lesser T; Javadpour M
    J Clin Neurosci; 2014 Oct; 21(10):1825-7. PubMed ID: 24938388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of voriconazole and vascular lesions in invasion of aspergillosis into the central nerve system].
    Ueno A; Hamano T; Fujii A; Matsunaga A; Naganuma S; Yoneda M; Itoh H; Kuriyama M
    Rinsho Shinkeigaku; 2009 Aug; 49(8):468-73. PubMed ID: 19827595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of
    Shearin S; Bell T
    Am J Health Syst Pharm; 2018 Jul; 75(13):958-961. PubMed ID: 29941535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
    Kohno S; Ogawa K; Kurashima A; Niki Y; Maesaki S
    Jpn J Antibiot; 2007 Dec; 60(6):321-34. PubMed ID: 18447204
    [No Abstract]   [Full Text] [Related]  

  • 33. Voriconazole as mono-therapy in orbitofrontal erosive aspergillosis without gross total resection: A case report and review of literature.
    Nowak S; Bollmann T; Rosenstengel C; Rathmann E; Ribback S; Ewert R; Schroeder HWS
    Clin Neurol Neurosurg; 2018 Sep; 172():93-95. PubMed ID: 29986203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
    Gutierrez F; Masia M; Ramos JM; Elia M; Rodriguez-Tudela JL; Cuenca-Estrella M
    Clin Infect Dis; 2005 Jun; 40(11):1706-7. PubMed ID: 15889381
    [No Abstract]   [Full Text] [Related]  

  • 35. Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.
    Vermeulen E; Maertens J; Meersseman P; Saegeman V; Dupont L; Lagrou K
    Clin Microbiol Infect; 2014 May; 20(5):O333-5. PubMed ID: 24102876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
    Wingard JR; Herbrecht R; Mauskopf J; Schlamm HT; Marciniak A; Roberts CS
    Transpl Infect Dis; 2007 Sep; 9(3):182-8. PubMed ID: 17605747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary aspergillosis in a kidney transplant recipient and review of the literature.
    Vijayvargiya P; Javed I; Moreno J; Mynt MA; Kotapka M; Zaki R; Ortiz J
    Transpl Infect Dis; 2013 Oct; 15(5):E196-200. PubMed ID: 24093964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
    Fincher T; Fulcher SF
    Cornea; 2007 Jun; 26(5):618-20. PubMed ID: 17525663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Invasive pulmonary aspergillosis complicating septic shock].
    Nourry L; Gagnadoux F; Pierrot M; Gourdier AL; Mercat A; Racineux JL
    Rev Mal Respir; 2005 Nov; 22(5 Pt 1):806-10. PubMed ID: 16272983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated invasive aspergillosis in an apparently immunocompetent host.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.